Loading...

MetLife

DB:MWZ
Snowflake Description

Established dividend payer and good value.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
MWZ
DB
$43B
Market Cap
  1. Home
  2. DE
  3. Insurance
Company description

MetLife, Inc. engages in the insurance, annuities, employee benefits, and asset management businesses. The last earnings update was 17 days ago. More info.


Add to Portfolio Compare Print
MWZ Share Price and Events
7 Day Returns
0.9%
DB:MWZ
1.9%
DE Insurance
1.2%
DE Market
1 Year Returns
4%
DB:MWZ
4.2%
DE Insurance
-11.2%
DE Market
MWZ Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
MetLife (MWZ) 0.9% 0.8% 4.9% 4% 8.4% 9%
DE Insurance 1.9% 5.1% 6.5% 4.2% 31.6% 47.6%
DE Market 1.2% 2.7% 1.7% -11.2% 12% 6.1%
1 Year Return vs Industry and Market
  • MWZ outperformed the Market in Germany which returned -11.2% over the past year.
Price Volatility
MWZ
Industry
5yr Volatility vs Market

Value

 Is MetLife undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of MetLife to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data    Our calculation method for this is changing soon.

Below are the data sources, inputs and calculation used to determine the intrinsic value for MetLife.

DB:MWZ Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model Excess Returns Model
Stable EPS Weighted future Return on Equity estimates from 9 analysts.
= Stable Book Value * Return on Equity
= $58.97 * 11.4%
$6.71
Book Value of Equity per Share Weighted future Book Value estimates from 8 analysts. $58.97
Discount Rate (Cost of Equity) See below 9.8%
Perpetual Growth Rate 10-Year DE Government Bond Rate 0.2%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for DB:MWZ
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year DE Govt Bond Rate 0.2%
Equity Risk Premium S&P Global 9.8%
Insurance Unlevered Beta Simply Wall St/ S&P Global 0.55
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.552 (1 + (1- 21%) (98.29%))
0.98
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
0.98
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 0.23% + (0.98 * 9.77%)
9.8%

Discounted Cash Flow Calculation for DB:MWZ using Excess Returns Model Model

The calculations below outline how an intrinsic value for MetLife is arrived at using the Excess Return Model. This approach is used for finance firms where free cash flow is difficult to estimate.

In the Excess Return Model the value of a firm can be written as the sum of capital invested currently in the firm and the present value of excess returns that the firm expects to make in the future.

The model is sensitive to the Return on Equity of the company versus the Cost of Equity, how these are calculated is detailed below the main calculation.

Note the calculations below are per share.

See our documentation to learn about this calculation.

DB:MWZ Value of Excess Returns
Calculation Result
Excess Returns = (Stable Return on equity – Cost of equity) (Book Value of Equity per share)
= (11.4% – 9.8%) * $58.97)
$0.92
Terminal Value of Excess Returns = Excess Returns / (Cost of Equity - Expected Growth Rate)
= $0.92 / (9.8% - 0.23%)
$9.65
Value of Equity = Book Value per share + Terminal Value of Excess Returns
= $58.97 + $9.65
$68.61
DB:MWZ Discount to Share Price
Calculation Result
Non-primary Listing Adjustment Factor 1 share in DB:MWZ represents 0.88422x of NYSE:MET
(This could be a different class, a depositary receipt, a different currency, or all of these things.)
0.88422x
Value per Share
(Listing Adjusted, EUR)
= Value per Share (USD) x Listing Adjustment Factor
= $ 68.61 x 0.88422
€60.67
Value per share (EUR) From above. €60.67
Current discount Discount to share price of €39.56
= -1 x (€39.56 - €60.67) / €60.67
34.8%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

Current Discount
Amount off the current price MetLife is available for.
Intrinsic value
35%
Share price is €39.56 vs Future cash flow value of €60.67
Current Discount Checks
For MetLife to be considered undervalued it must be available for at least 20% below the current price. Less than 40% is even better.
  • MetLife's share price is below the future cash flow value, and at a moderate discount (> 20%).
  • MetLife's share price is below the future cash flow value, but not at a substantial discount (< 40%).
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for MetLife's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are MetLife's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
DB:MWZ PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2018-12-31) in USD $4.91
NYSE:MET Share Price ** NYSE (2019-02-22) in USD $44.74
Germany Insurance Industry PE Ratio Median Figure of 6 Publicly-Listed Insurance Companies 11.5x
Germany Market PE Ratio Median Figure of 420 Publicly-Listed Companies 18.04x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of MetLife.

DB:MWZ PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= NYSE:MET Share Price ÷ EPS (both in USD)

= 44.74 ÷ 4.91

9.11x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • MetLife is good value based on earnings compared to the DE Insurance industry average.
  • MetLife is good value based on earnings compared to the Germany market.
Price based on expected Growth
Does MetLife's expected growth come at a high price?
Raw Data
DB:MWZ PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section 9.11x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 9 Analysts
2%per year
Germany Insurance Industry PEG Ratio Median Figure of 5 Publicly-Listed Insurance Companies 1.55x
Germany Market PEG Ratio Median Figure of 277 Publicly-Listed Companies 1.4x

*Line of best fit is calculated by linear regression .

DB:MWZ PEG (Price to Earnings to Growth) Ratio Calculation
Calculation Outcome
PEG Ratio

= PE Ratio ÷ Net Income Annual Growth Rate

= 9.11x ÷ 2%

4.49x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • MetLife is poor value based on expected growth next year.
Price based on value of assets
What value do investors place on MetLife's assets?
Raw Data
DB:MWZ PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2018-12-31) in USD $55.02
NYSE:MET Share Price * NYSE (2019-02-22) in USD $44.74
Germany Insurance Industry PB Ratio Median Figure of 6 Publicly-Listed Insurance Companies 1.09x
Germany Market PB Ratio Median Figure of 565 Publicly-Listed Companies 1.78x
DB:MWZ PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= NYSE:MET Share Price ÷ Book Value per Share (both in USD)

= 44.74 ÷ 55.02

0.81x

* Primary Listing of MetLife.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • MetLife is good value based on assets compared to the DE Insurance industry average.
X
Value checks
We assess MetLife's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Insurance industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Insurance industry average (and greater than 0)? (1 check)
  5. MetLife has a total score of 4/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

Future Performance

 How is MetLife expected to perform in the next 1 to 3 years based on estimates from 9 analysts?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
2%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is MetLife expected to grow at an attractive rate?
  • MetLife's earnings growth is expected to exceed the low risk savings rate of 0.2%.
Growth vs Market Checks
  • MetLife's earnings growth is positive but not above the Germany market average.
  • MetLife's revenues are expected to decrease over the next 1-3 years, this is below the Germany market average.
Annual Growth Rates Comparison
Raw Data
DB:MWZ Future Growth Rates Data Sources
Data Point Source Value (per year)
DB:MWZ Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 9 Analysts 2%
DB:MWZ Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 9 Analysts -0.4%
Germany Insurance Industry Earnings Growth Rate Market Cap Weighted Average 6.4%
Germany Insurance Industry Revenue Growth Rate Market Cap Weighted Average 7.7%
Germany Market Earnings Growth Rate Market Cap Weighted Average 10%
Germany Market Revenue Growth Rate Market Cap Weighted Average 5.1%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
DB:MWZ Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (1 month ago) See Below
Future Estimates Average of up to 9 Analyst Estimates (S&P Global) See Below
All numbers in USD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
DB:MWZ Future Estimates Data
Date (Data in USD Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2021-12-31 67,079 5,237 4
2020-12-31 66,367 5,069 8
2019-12-31 64,602 4,754 8
DB:MWZ Past Financials Data
Date (Data in USD Millions) Revenue Cash Flow Net Income *
2018-12-31 67,941 4,982
2018-09-30 68,081 12,487 5,244
2018-06-30 67,954 13,688 5,235
2018-03-31 62,102 11,481 5,197
2017-12-31 62,266 12,283 4,893
2017-09-30 59,263 15,876 1,893
2017-06-30 58,908 14,069 2,044
2017-03-31 57,263 14,959 2,229
2016-12-31 60,732 14,774 3,481
2016-09-30 65,209 13,733 4,994
2016-06-30 67,255 13,445 5,169
2016-03-31 69,952 13,356 5,219

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • MetLife's earnings are expected to grow by 2% yearly, however this is not considered high growth (20% yearly).
  • MetLife's revenue is expected to decrease over the next 1-3 years, this is not considered high growth.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
DB:MWZ Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (1 month ago) See Below
Future Estimates Average of up to 9 Analyst Estimates (S&P Global) See Below

All data from MetLife Company Filings, last reported 1 month ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

DB:MWZ Future Estimates Data
Date (Data in USD Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2021-12-31 6.29 6.29 6.29 1.00
2020-12-31 5.56 6.05 5.11 4.00
2019-12-31 5.08 5.45 4.80 5.00
DB:MWZ Past Financials Data
Date (Data in USD Millions) EPS *
2018-12-31 4.91
2018-09-30 5.12
2018-06-30 5.03
2018-03-31 4.92
2017-12-31 4.57
2017-09-30 1.75
2017-06-30 1.87
2017-03-31 2.03
2016-12-31 3.16
2016-09-30 4.53
2016-06-30 4.67
2016-03-31 4.70

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • MetLife is not expected to efficiently use shareholders’ funds in the future (Return on Equity less than 20%).
X
Future performance checks
We assess MetLife's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Germany market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Germany market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
MetLife has a total score of 1/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

Past Performance

  How has MetLife performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare MetLife's growth in the last year to its industry (Insurance).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • MetLife's year on year earnings growth rate was negative over the past 5 years, however the most recent earnings are above average.
  • MetLife's 1-year earnings growth exceeds its 5-year average (1.8% vs -3.2%)
  • MetLife's earnings growth has not exceeded the DE Insurance industry average in the past year (1.8% vs 9.6%).
Earnings and Revenue History
MetLife's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from MetLife Company Filings, last reported 1 month ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

DB:MWZ Past Revenue, Cash Flow and Net Income Data
Date (Data in USD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2018-12-31 67,941.00 4,982.00
2018-09-30 68,081.00 5,244.00 -107.00
2018-06-30 67,954.00 5,235.00 -68.00
2018-03-31 62,102.00 5,197.00
2017-12-31 62,266.00 4,893.00
2017-09-30 59,263.00 1,893.00 -33.00
2017-06-30 58,908.00 2,044.00 -28.00
2017-03-31 57,263.00 2,229.00 -97.00
2016-12-31 60,732.00 3,481.00
2016-09-30 65,209.00 4,994.00 368.00
2016-06-30 67,255.00 5,169.00 355.00
2016-03-31 69,952.00 5,219.00 342.00
2015-12-31 61,257.00 3,891.00
2015-09-30 71,888.00 5,857.00 333.00
2015-06-30 72,677.00 6,724.00 350.00
2015-03-31 74,596.00 7,017.00 359.00
2014-12-31 73,265.00 6,190.00 361.00
2014-09-30 72,639.00 5,576.00 366.00
2014-06-30 70,514.00 4,452.00 360.00
2014-03-31 68,330.00 3,586.00 368.00
2013-12-31 69,396.00 3,244.00 376.00
2013-09-30 68,313.00 2,433.00 366.00
2013-06-30 68,472.00 509.00 384.00
2013-03-31 70,587.00 2,301.00 395.00
2012-12-31 68,571.00 1,154.00 422.00
2012-09-30 67,696.00 2,023.00 446.00
2012-06-30 71,017.00 6,425.00 438.00
2012-03-31 70,048.00 5,202.00 439.00

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • MetLife has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
  • MetLife used its assets less efficiently than the DE Insurance industry average last year based on Return on Assets.
  • MetLife has significantly improved its use of capital last year versus 3 years ago (Return on Capital Employed).
X
Past performance checks
We assess MetLife's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Insurance industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
MetLife has a total score of 2/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

Health

 How is MetLife's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up MetLife's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • MetLife is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • MetLife's long term commitments exceed its cash and other short term assets.
Balance sheet
This treemap shows a more detailed breakdown of MetLife's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • Low level of unsold assets.
  • Debt is covered by short term assets, assets are 1x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from MetLife Company Filings, last reported 1 month ago.

DB:MWZ Past Debt and Equity Data
Date (Data in USD Millions) Total Equity Total Debt Cash & Short Term Investments
2018-12-31 52,958.00 42,098.00 19,758.00
2018-09-30 51,809.00 95,639.00 21,768.00
2018-06-30 53,832.00 97,797.00 24,740.00
2018-03-31 56,508.00 83,431.00 23,792.00
2017-12-31 58,870.00 99,023.00 23,134.00
2017-09-30 56,944.00 51,327.00 25,954.00
2017-06-30 69,669.00 61,994.00 31,629.00
2017-03-31 68,108.00 76,662.00 34,235.00
2016-12-31 67,702.00 97,924.00 26,735.00
2016-09-30 78,466.00 71,600.00 42,970.00
2016-06-30 79,373.00 73,316.00 43,199.00
2016-03-31 75,965.00 69,772.00 38,597.00
2015-12-31 68,496.00 114,374.00 31,889.00
2015-09-30 71,067.00 64,853.00 36,147.00
2015-06-30 69,989.00 77,312.00 31,176.00
2015-03-31 74,409.00 65,208.00 33,585.00
2014-12-31 72,659.00 113,157.00 29,138.00
2014-09-30 71,401.00 59,571.00 28,518.00
2014-06-30 70,282.00 59,372.00 26,913.00
2014-03-31 66,439.00 58,990.00 29,285.00
2013-12-31 62,983.00 74,219.00 27,796.00
2013-09-30 61,378.00 60,090.00 30,949.00
2013-06-30 60,538.00 61,812.00 29,547.00
2013-03-31 64,968.00 63,225.00 33,581.00
2012-12-31 64,958.00 78,705.00 43,158.00
2012-09-30 64,550.00 68,379.00 43,553.00
2012-06-30 62,824.00 69,224.00 46,770.00
2012-03-31 59,124.00 66,089.00 39,397.00
  • MetLife's level of debt (79.5%) compared to net worth is high (greater than 40%).
  • The level of debt compared to net worth has been reduced over the past 5 years (117.5% vs 79.5% today).
  • Debt is well covered by operating cash flow (29.7%, greater than 20% of total debt).
  • Interest payments on debt are well covered by earnings (EBIT is 6.7x coverage).
X
Financial health checks
We assess MetLife's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. MetLife has a total score of 4/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

Dividends

 What is MetLife's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
3.76%
Current annual income from MetLife dividends. Estimated to be 4.1% next year.
If you bought €2,000 of MetLife shares you are expected to receive €75 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • MetLife's pays a higher dividend yield than the bottom 25% of dividend payers in Germany (1.54%).
  • MetLife's dividend is below the markets top 25% of dividend payers in Germany (3.93%).
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
DB:MWZ Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 9 Analyst Estimates (S&P Global) See Below
Germany Insurance Industry Average Dividend Yield Market Cap Weighted Average of 6 Stocks 4.4%
Germany Market Average Dividend Yield Market Cap Weighted Average of 332 Stocks 3%
Germany Minimum Threshold Dividend Yield 10th Percentile 0.9%
Germany Bottom 25% Dividend Yield 25th Percentile 1.5%
Germany Top 25% Dividend Yield 75th Percentile 3.9%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

DB:MWZ Future Dividends Estimate Data
Date (Data in $) Dividend per Share (annual) Avg. No. Analysts
2021-12-31 1.96 6.00
2020-12-31 1.85 12.00
2019-12-31 1.74 11.00
DB:MWZ Past Annualized Dividends Data
Date (Data in $) Dividend per share (annual) Avg. Yield (%)
2019-01-07 1.680 3.781
2018-10-23 1.680 4.008
2018-07-06 1.680 3.681
2018-04-24 1.680 3.621
2018-01-05 1.600 3.346
2017-10-24 1.600 3.049
2017-07-07 1.600 3.136
2017-04-25 1.600 3.058
2017-01-06 1.600 3.012
2016-10-25 1.600 3.021
2016-07-07 1.600 3.707
2016-04-26 1.600 3.721
2016-01-06 1.500 3.550
2015-10-27 1.500 3.038
2015-04-28 1.500 2.875
2015-01-06 1.400 2.777
2014-10-28 1.400 2.577
2014-07-07 1.400 2.624
2014-04-22 1.400 2.643
2014-01-06 1.100 2.138
2013-10-22 1.100 2.154
2013-06-25 1.100 2.285
2013-04-23 1.100 2.592
2013-01-04 0.740 1.997
2012-10-23 0.740 2.226
2012-08-07 0.740 2.118
2012-08-01 0.740 2.273
2011-10-25 0.740 2.228
2010-10-26 0.740 1.857
2009-10-29 0.740 1.906
2009-03-02 0.740 2.518
2009-02-24 0.740 3.621

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Dividends per share have been stable in the past 10 years.
  • Dividends per share have increased over the past 10 years.
Current Payout to shareholders
What portion of MetLife's earnings are paid to the shareholders as a dividend.
  • Dividends paid are well covered by earnings (3x coverage).
Future Payout to shareholders
  • Dividends after 3 years are expected to be well covered by earnings (3.3x coverage).
X
Income/ dividend checks
We assess MetLife's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 0.9%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can MetLife afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. MetLife has a total score of 5/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

Management

 What is the CEO of MetLife's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Steve Kandarian
COMPENSATION $14,726,721
AGE 65
TENURE AS CEO 7.8 years
CEO Bio

Mr. Steven Albert Kandarian, also known as Steve, J.D., has been the Chairman of the Board of MetLife, Inc. since January 1, 2012 and has been its Chief Executive Officer and President since May 1, 2011. Mr. Kandarian served as the Chief Executive Officer, Chairman of the Board and President at New England Life Insurance Company. He has been the Chief Executive Officer and President at Metropolitan Life Insurance Company since May 1, 2011 and has been its Chairman since January 1, 2012. He founded Orion Partners, L.P. Mr. Kandarian served as an Executive Vice President and Chief Investment Officer at MetLife, Inc. from April 2005 to April 2011. He joined MetLife on April 11, 2005. Mr. Kandarian served as Chief Investment Officer at Metropolitan Life Insurance Company since April 11, 2005, Executive Vice President since April 2005 and also served as its Head of the Investment Organization. He served as Managing Director of Pension Benefit Guaranty Corporation from December 02, 2001 to February 21, 2004. He served as Managing Director of Orion Capital Holdings II, L.P. and Orion Capital Holdings, LP. Mr. Kandarian served as an Executive Vice President, Head of the Investment Organization and Chief Investment Officer of Metropolitan Life Insurance Company, Asset Management Arm. Mr. Kandarian served as Managing Director of Orion Partners, L.P. from 1993 to 2001. He served as the Managing Director of Lee Capital Holdings, LLC from 1984 to 1990, where he completed 10 private equity transactions with an IRR of over 100%. Mr. Kandarian served as an Investment Banker at State Street Bank and Rotan Mosle. Mr. Kandarian served as Chairman of Reinsurance Group of America Inc since January 18, 2007. He has been a Director of MetLife, Inc. since April 26, 2011 and Metropolitan Life Insurance Company since 2008. He has been a Director at Exxon Mobil Corp., since February 01, 2018. He serves as a Director of Institute of International Finance, Inc and Damon Runyon Cancer Research Foundation. He serves as a Director of The Partnership for New York City, Inc. and Lincoln Center for the Performing Arts, Inc. He was Founder and President, Eagle Capital Holdings, where Mr. Kandarian formed a private merchant bank to sponsor equity investments in small and mid-sized businesses from 1990 to 1993. He has been Trustee at Orion Partners, LP since 2002 and The DLB Fund Group since 2002. He is the Chair of Insurance Regulatory Committee of the IIF. He served as Independent Trustee of Barings Participation Investors (formerly, Babson Capital Participation Investors and MassMutual Participation Investors) since 2002. He served as Director of Reinsurance Group of America Inc. from January 18, 2007 to September 2008 and served as its Presiding Director since February 2007. He served as an Executive Director of Pension Benefit Guaranty Corporation from December 2, 2001 to February 21, 2004. He is a member of Business Council and Business Roundtable.He served as Trustee of Barings Corporate Investors (formerly, Babson Capital Corporate Investors and MassMutual Corporate Investors) since 2002. He served as a Member of the Board of Trustees of MassMutual Premier Funds. He received a B.A. in Economics from Clark University, an M.B.A. from Harvard Business School and a J.D. from Georgetown University Law Center in Technologies and Uniform Information Services.

CEO Compensation
  • Steve's compensation has been consistent with company performance over the past year.
  • Steve's remuneration is higher than average for companies of similar size in Germany.
Management Team Tenure

Average tenure and age of the MetLife management team in years:

4.1
Average Tenure
56
Average Age
  • The tenure for the MetLife management team is about average.
Management Team

Steve Kandarian

TITLE
Chairman
COMPENSATION
$15M
AGE
65
TENURE
7.8 yrs

Marty Lippert

TITLE
Executive VP and Head of Global Technology & Operations
COMPENSATION
$6M
AGE
58
TENURE
7.4 yrs

Steve Goulart

TITLE
Executive VP & Chief Investment Officer
COMPENSATION
$5M
AGE
59
TENURE
7.8 yrs

Michel Khalaf

TITLE
President of U.S. Business & EMEA
COMPENSATION
$6M
AGE
54
TENURE
7.3 yrs

John McCallion

TITLE
Executive VP & CFO
AGE
44
TENURE
0.8 yrs

Bill O'Donnell

TITLE
CFO of U.S.
AGE
50
TENURE
1.7 yrs

John Hall

TITLE
Senior VP & Head of Investor Relations

Stephen Gauster

TITLE
Executive VP & General Counsel
AGE
48
TENURE
1.6 yrs

Randy Clerihue

TITLE
Chief Communications Officer
TENURE
0.8 yrs

Esther Lee

TITLE
Executive VP & Global Chief Marketing Officer
AGE
59
TENURE
4.1 yrs
Board of Directors Tenure

Average tenure and age of the MetLife board of directors in years:

5.9
Average Tenure
64
Average Age
  • The tenure for the MetLife board of directors is about average.
Board of Directors

Eric Sacha Clurfain

TITLE
Chairman
AGE
46

Cheryl Grisé

TITLE
Director
COMPENSATION
$164K
AGE
65
TENURE
15 yrs

Steve Kandarian

TITLE
Chairman
COMPENSATION
$15M
AGE
65
TENURE
7.1 yrs

Jim Kilts

TITLE
Director
COMPENSATION
$172K
AGE
70
TENURE
14.1 yrs

Bill Kennard

TITLE
Director
COMPENSATION
$164K
AGE
61
TENURE
5.4 yrs

Ned Kelly

TITLE
Director
COMPENSATION
$169K
AGE
64
TENURE
4 yrs

David Herzog

TITLE
Director
COMPENSATION
$172K
AGE
59
TENURE
2.3 yrs

Robert Hubbard

TITLE
Independent Lead Director
COMPENSATION
$182K
AGE
59
TENURE
1.7 yrs

Cathy Kinney

TITLE
Independent Director
COMPENSATION
$152K
AGE
66
TENURE
9.8 yrs

Carlos Gutierrez

TITLE
Director
COMPENSATION
$152K
AGE
64
TENURE
5.9 yrs
Who owns this company?
Recent Insider Trading
  • More shares have been bought than sold by MetLife insiders in the past 3 months.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (€) Value (€)
19. Dec 18 Buy Carlos Gutierrez Individual 17. Dec 18 17. Dec 18 6,400 €34.41 €220,256
10. May 18 Buy Gerald Hassell Individual 09. May 18 09. May 18 10,000 €38.94 €389,436
X
Management checks
We assess MetLife's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. MetLife has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

News

Simply Wall St News

Company Info

Map
Description

MetLife, Inc. engages in the insurance, annuities, employee benefits, and asset management businesses. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short- and long-term disability, individual disability, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and stable value products, including general and separate account guaranteed interest contracts, and private floating rate funding agreements. It also provides pension risk transfers, institutional income annuities, tort settlements, and capital markets investment products; and other products and services, such as life insurance products and funding agreements for funding postretirement benefits, as well as company, bank, or trust-owned life insurance used to finance nonqualified benefit programs for executives. In addition, the company offers automobile, homeowners’, and personal excess liability, as well as small business owners’ property, liability, and business interruption insurance products. Further, it provides fixed annuities and pension products; medical and credit insurance products; variable, universal, term, endowment, and whole life insurance products; variable, and fixed and indexed-linked annuities; and protection against costs of long-term health care services. MetLife, Inc. has a strategic alliance with Ernst & Young LLP. The company serves individuals, corporations and their employees, and other institutions through independent agents, property and casualty specialists, sales forces, sales teams and relationship managers, and other organizations, as well as through career agency, bancassurance, direct marketing, brokerage, and other third-party distribution and e-commerce channels. MetLife, Inc. was founded in 1863 and is headquartered in New York, New York.

Details
Name: MetLife, Inc.
MWZ
Exchange: DB
Founded: 1863
$37,770,275,540
957,270,842
Website: http://www.metlife.com
Address: MetLife, Inc.
200 Park Avenue,
New York,
New York, 10166,
United States
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
NYSE MET Common Stock New York Stock Exchange US USD 05. Apr 2000
DB MWZ Common Stock Deutsche Boerse AG DE EUR 05. Apr 2000
LSE 0K0X Common Stock London Stock Exchange GB USD 05. Apr 2000
BMV MET * Common Stock Bolsa Mexicana de Valores MX MXN 05. Apr 2000
NYSE MET.PRA PFD A FLT RATE New York Stock Exchange US USD 09. Jun 2005
NYSE MET.PRE 5.625 NCUM PFD E New York Stock Exchange US USD 31. May 2018
BOVESPA METB34 EACH BDR REPR 1 COM STK USD0.01 Bolsa de Valores de Sao Paulo BR BRL 24. Aug 2015
Number of employees
Current staff
Staff numbers
0
MetLife employees.
Industry
Life and Health Insurance
Insurance
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/02/23 20:55
End of day share price update: 2019/02/22 00:00
Last estimates confirmation: 2019/02/20
Last earnings filing: 2019/02/06
Last earnings reported: 2018/12/31
Last annual earnings reported: 2018/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.